Cannabis and Hemp Industry Investment News

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) has announced the appointment of Nathan Coyle, the company's corporate controller as its interim chief financial officer with immediate effect, following the departure of Donal Carroll.

The company noted that Coyle joined FSD Pharma as corporate controller in 2020 and has 15 years of executive business experience as a finance leader in both public and private roles. He was previously with Illinois Tool Works where he was a key player in restructuring the organization, shaping the growth and streamlining businesses within his industrial packaging segment.

READ: FSD Pharma in license agreement with Innovet Italia to develop FDA-approved drugs to treat gastrointestinal diseases in dogs and cats

After ITW, Coyle worked with a private organization implementing the same corporate strategies to maximize growth. He holds a Bachelor of Business Administration with honours from Brock University and is a Chartered Professional Accountant.

FSD Pharma Inc. is a publicly-traded holding company. FSD BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound, ultra-micro PEA by down-regulating the cytokines to effectuate an anti-inflammatory response.

Heritage Cannabis Holdings Corp (CSE:CANN) (OTCQX:HERTF) (FRA:2UE) has announced the launch of ArthroCBD, an innovative hemp brand created to help people seeking “symptomatic relief.”

Clinically tested ArthroCBD, is a softgel capsule with 25 mg of CBD and 6 mg of Beta caryophyllene. It is formulated using VESIsorb technology, which boosts absorption, compared to other oral CBD products on the market, said the company.

The improved absorption levels result in “rapid onset of action and long-lasting relief,” Heritage Cannabis added. ArthroCBD has all traces of THC removed to avoid the adverse effects people sometimes suffer from other hemp-based products. The new product line is now available on arthrocbd.com.

READ: Heritage Cannabis expands into the US with its 3Fifteen Primo Cannabis partnership

“We are excited to launch our clinically tested ArthroCBD softgel capsules for those seeking daily relief from physical strain. Physicians, pharmacists, and other health care practitioners all want the same thing – to provide the best treatment for patients with the least side effects. ArthroCBD now provides that option with a highly effective hemp-based CBD product,” said Umar Syed, president of medical products at Heritage Cannabis in a statement.

Heritage Cannabis (CSE: CANN- OTCQX: HERTF) CEO Clint Sharples joined Steve Darling from Proactive to share news the company agreed to a 5 year five-year partnership with 3Fifteen Primo Cannabis. 3Fifteen operates with five dispensary licenses of which two are in operation and three are in construction phase the state of Missouri.

Sharples discusses that move into the market and he also shares with Proactive about another key milestone, the launch of their e-commerce US medical site arthrocbd.com.

AgraFlora Organics International Inc (CSE:AGRA) (FRA:PU31) (OTCPINK:AGFAF) announced that it has appointed veteran executive Fiona Fitzmaurice as its new CFO.

Fitzmaurice brings more than 14 years of experience in accounting and financial control, the company said, serving both public and private companies. Fitzmaurice has previously worked as CFO of companies including MacDonald Mines Exploration Ltd., Pasofino Gold and Mojave Jane Brands. She also has extensive experience with corporate audits, prospectus filings, private placements, financings and corporate acquisitions. 

AgraFlora’s former CFO, Peter Nguyen, has amicably agreed to depart the company in order to “facilitate Ms. Fitzmaurice’s transition as the new steward of AgraFlora’s finances,” the company said.

READ: AgraFlora Organics subsidiary starts supplying THC Teskits to Stadapharm GmbH in Germany

“On behalf of the board of directors, I am pleased to welcome Fiona to AgraFlora’s management team as we continue to evolve the company’s streamlined corporate strategy and execute on our near-term goal of generating revenues from our core assets,” CEO Elise Coppens said in a statement. 

Heritage Cannabis Holdings Corp (CSE:CANN) (OTCQX:HERTF) (FRA:2UE) announced a five-year partnership with Como Health LLC, doing business as 3Fifteen Primo Cannabis, which will see Heritage produce branded products for medical cannabis consumers in the US state of Missouri. 

Under the partnership agreement, Heritage will supply production equipment to 3Fifteen, provide training and supervision of staff on its proprietary methods of extraction and oil production, and shelf minimums with be granted for Heritage’s branded products in 3Fifteen’s Missouri dispensaries.  

“With strong market growth projected in Missouri, we believe this is the right time to enter the US and with a strategic partner like 3Fifteen, we are creating a blueprint we can use to continue our state-by-state expansion,” Heritage Cannabis Holdings President of Recreational Cannabis David Schwede said in a statement. 

READ: Heritage Cannabis taps Merida Capital to accelerate its US product distribution initiative

“With our extraction expertise and inspired branding capabilities, along with 3Fifteen’s impressive market penetration, we expect Heritage’s branded offerings to be in high demand,” Schwede added.

Fidelity Minerals Corp ( ) (OTC:SAIDF) (FRA:S5GM) announced the closing of a  previously announced non-brokered private placement in which the company issued 9,9 million units at $0.125 per unit for gross proceeds of $1,237,090. Roughly 1 million units were subscribed by Lions Bay Capital Inc, a control person, and 141,120 units were subscribed by management. Each unit consists of one common share and one transferable share purchase warrant exercisable at $0.15 per share until April 16, 2023. 

Inc (CVE: EXRO), () CEO Sue Ozdemir told shareholders that the company had spurred innovation with its inaugural Coil Driver product, and is rapidly advancing several products towards commercialization. The Coil Driver works by expanding the capabilities of powertrains by enabling two separate torque profiles within an electric motor. The controller automatically selects the appropriate configuration in real-time so that power and efficiency are intelligently optimized. “As government regulations globally set standards for net zero carbon emissions, mobility manufacturers are looking for technology that will help to deliver the required performance in a cost-effective platform,” Ozdemir said in her annual shareholder letter.

(), which is in the process of changing its name to American Battery Technology Company (ABTC), announced that it has responded to the Department of Energy's Request for Information after the company outlined risks inherent in the current battery critical materials supply chain. ABTC said it has identified the recycling of lithium batteries using next generation extraction technologies as the fastest, most economical and environmentally-friendly way to increase domestic sources of critical battery materials.

Atlas Engineered Products Ltd () (OTCMTS:APEUF) posted fourth-quarter results that saw its revenue jump 22% year-over-year on the back of demand for its products and strength in the construction industry. For the period ended December 31, 2020, the Canadian wood truss and engineering company, reported revenue of $11,057,939, compared to $9,027,723 in the fourth quarter of 2019. “This increase represents the company's best fourth quarter to date,” said Atlas. Overall revenue for the year ended December 31, 2020 was $35,734,415, up 3%, compared to revenue of $34,763,527 for the year ended December 31, 2019, despite the coronavirus (COVID-19) pandemic.

Heritage Cannabis Holdings Corp () () (FRA:2UE) said that its subsidiary CannaCure Corp has been granted an amended sales license by Health Canada from April 12, 2021, for selling dried cannabis products, including flower and pre-rolls, directly to the provincial and territorial cannabis boards. 

The Toronto-headquartered company focused on the production and sale of medical and recreational hemp-based and cannabis products, already offers extract and extract derivative products across Canada through its Pura Vida, Purefarma, RAD, Premium 5, and feelgood brands.  Heritage said that with the amended license, it will have the opportunity to address the “largest category in terms of revenue in the Canadian cannabis market, topping 67% of total product sales in 2020.” 

In the beginning of May, the company will add dried cannabis products to its already expansive portfolio of products, starting with the introduction of items under its popular RAD brand. 

READ: Heritage Cannabis taps Merida Capital to accelerate its US product distribution initiative

“Having the CannaCure sales license amended by Health Canada to sell dried cannabis is another accomplishment for the Heritage team and allows us to enter a high-volume product category and deliver our newly developed SKUs to consumers across Canada through the provincial and territorial boards, as well as select online consumer platforms,” Heritage CEO Clint Sharples said in a statement.

AgraFlora Organics International Inc (CSE: AGRA) (FRA:PU31) (OTCPINK:AGFAF) announced that its German pharmaceutical wholesale subsidiary, Farmako GmbH, has begun supplying its proprietary THC Testkits to Stadapharm GmbH. 

The THC Testkit was developed and produced by Farmako in-house as a tool for pharmacists to detect THC and identify medical cannabis flowers and extracts easily, quickly and at low cost, the company said. 

Stadapharm, which is responsible for the specialty pharmaceuticals business within the German STADA Group, is expected to enter the medical cannabis market in the second quarter of 2021. The company plans to launch its own THC cannabis flower products and extracts and will also offer the Farmako THC Testkits, the company said. 

READ: AgraFlora Organics CEO says recent asset sales give ‘us the financial flexibility’ to enter lucrative markets

“Katrin and everyone at Farmako continue to demonstrate their ingenuity and passion for the cannabis industry in Germany,” AgraFlora CEO Elise Coppens said in a statement. “I am very proud of the team and commend their efforts to develop the THC Testkit in-house, obtain patent protection, bring it to market and secure the supply agreement with Stadapharm.”

Heritage Cannabis (CSE: CANN- OTCQX: HERTF) CEO Clint Sharples joined Steve Darling from Proactive to share details the company has expanded its relationship with Merida Capital Holdings. Merida, the largest non-insider investor in Premium 5, became a strategic shareholder in Heritage back in January of 2021.

Sharples telling Proactive this expanded agreement will give Heritage distribution into the U.S. with the focus to start initially in Michigan, Missouri, West Virginia and California.

AgraFlora Organics International Inc (CSE:AGRA) (OTCMKTS:AGFAF) (FRA:PU31) CEO Elise Coppens told shareholders the “transformational sale” of two of its assets provided the company with the financial flexibility to look at entering more lucrative markets. 

On Tuesday, AgraFlora struck an agreement to sell The Edibles & Infusions Corporation (EIC), an entity in which AgraFlora owns 43%, to Organigram Holdings Inc (TSE:OGI) (NASDAQ:OGI) (FRA:0OG) for $35 million. 

Earlier this month, the Vancouver, British Columbia-based company which grows, distributes, and markets premium cannabis and cannabis-infused products, also struck a definitive agreement to sell its wholly-owned subsidiary AAA Heidelberg Inc (AAA) for around C$1 million in cash. 

READ: AgraFlora and other owners to sell edibles business for $35M to Organigram Holdings

“It is always a difficult decision to sell a significant asset, however, the timing of our review of all company assets aligned well with the opportunity to receive the value that we did for this facility. Ultimately, the sale of AgraFlora’s share of EIC was a strategic decision,” Coppens said in a letter to shareholders.

Heritage Cannabis Holdings Corp (CSE:CANN) (OTCQX:HERTF) (FRA:2UE) said it has expanded its relationship with Merida Capital Holdings to rapidly advance Heritage’s US product distribution strategy. 

Merida, a strategic shareholder in Heritage Cannabis, will help introduce Heritage’s brands and products into select states where medical and/or recreational cannabis is legal, or soon expected to be, starting with Michigan, Missouri, West Virginia, and California. 

“Entering the US cannabis market with a clear path and strong partner is a pivotal and transformational moment for Heritage. The work done over the past three months with integrating Premium 5, increasing working capital and removing restrictive lending covenants has laid the foundation for today’s announcement,” Heritage Cannabis President David Schwede said in a statement. 

READ: Heritage Cannabis is pioneering the seed-to-sale cannabis model

“We are excited to reveal more of our vision to create shareholder value through this accretive expansion. Further, our growing relationship with Merida underscores the strength of the business and will accelerate our state-by-state expansion and access to nine purposefully selected US markets, including the initial four we’re targeting immediately,” Schwede added.

Heritage Cannabis Holdings Corp () () (FRA:2UE) said it has received the first order from New Brunswick’s legal recreational cannabis retailer, Cannabis NB, to sell its Premium 5 and RAD branded products in the province. 

The company noted that beginning in April, customers in New Brunswick will be able to purchase RAD Vapes, RAD Shatter, RAD Crumble, RAD Live Resin, and RAD CBD Isolate, as well as Premium 5 Full Spectrum Extract and Live Resin Caviar. 

“We are very pleased to be entering the New Brunswick market with Cannabis NB’s order of our RAD and Premium 5 brands,” Heritage Cannabis Recreational Division President David Schwede said in a statement.   

READ: Heritage Cannabis achieves its first C$1M revenue week in March on strong demand for its brands

“Consumers in New Brunswick will have a broad range of choice of extract and extract derivative products across our high-quality Premium 5 and favourably priced RAD brands, and we expect the positive reaction and strong following for our products to continue growing,” he added.

AgraFlora Organics International Inc () () (FRA:PU31) has said it and its shareholders have struck an agreement to sell The Edibles & Infusions Corporation (EIC), an entity in which AgraFlora owns 43%, to Organigram Holdings Inc (TSE:OGI) (NASDAQ:OGI) for $35 million.

The Vancouver, British Columbia-based company which grows, distributes, and markets premium cannabis and cannabis-infused products, said that the EIC transaction “strongly positions” AgraFlora with its net share of up to $35 million in aggregate proceeds as it continues to evolve its competitive strategy within the changing global cannabis industry.

“AgraFlora and Organigram have enjoyed working towards the closing of the EIC Transaction,” AgraFlora CEO Elise Coppens said in a statement.

READ: AgraFlora Organics International to sell non-core subsidiary AAA Heidelberg

Coppens noted that the EIC facility was designed to handle both smaller-batch artisanal manufacturing and, “more importantly, large-scale nutraceutical-grade and high-efficiency production with view to gaining EU GMP certification.”

AgraFlora Organics International Inc (CSE:AGRA) (FRA:PU31) (OTCPINK:AGFAF), the cannabis-focused company, said it had struck a definitive agreement to sell its wholly-owned subsidiary AAA Heidelberg Inc (AAA) for around C$1 million in cash.

READ: AgraFlora Organics names Canadian cannabis industry veteran Elise Coppens as its new CEO and board director

AAA operates an 8,800 square foot (sq ft) indoor growing facility in London, Ontario and the closing of the deal is expected to occur in the second quarter of 2021.

"With the positive developments being experienced in Delta, BC at our Propagation Services Canada facility, the AAA Heidelberg subsidiary was deemed to be non-core to the company," said Elise Coppens, chief executive and director of AgraFlora.

"Further, streamlining AgraFlora’s strategy, focusing on our core assets and benefiting from the cash proceeds of this Transaction are all high priorities for us at this transformative time.

Mojave Jane Brands Inc (CSE:JANE) (OTCMKTS:HHPHF) (FRA:0HCN) has successfully rebranded as Mojave Brands Inc and its ticker symbol will change to ‘MOJO’ on the Canadian Securities Exchange on or around Monday, April 5. 

In connection with the change, the company is implementing a share consolidation on a 25:1 basis. “Following the share consolidation, the company will have approximately 4,492,426 common shares issued and outstanding,” Mojave said in a statement.   

The Toronto-based company said all shareholders who submit a duly completed letter of transmittal along with their respective pre-consolidation share certificates to Computershare will receive a post-consolidation share certificate or direct registration advice representing the post-consolidation shares and under the new name of the company. 

READ: Mojave Jane Brands appoints Mervyn Pinto as CEO, CFO and director

Mojave had been focused on developing cannabis extracts, distillates and concentrates, and its CALIGOLD brand of cannabis-infused chocolate and edibles.

Heritage Cannabis (CSE: CANN- OTCQX: HERTF) CEO Clint Sharples joined Steve Darling from Proactive to share details the company has announced the company will be launching several new medical products formulated with the patented VESIsorb delivery system technology in the U.S.

Sharples telling Proactive the first product, through their subsidiary Opticann, will be ArthroCBD soft gel capsules which are expected to be launched on April 19th.

Sharples also said the company has also signed an expansion of its supply and distribution agreement with Geocann for the Canadian marketplace. 

Heritage Cannabis Holdings Corp (CSE:CANN) (OTCQX:HERTF) (FRA:2UE) revealed on Thursday that this year, it would launch in the US, several new medical products, formulated with its patented VESIsorb drug delivery technology through its subsidiary Opticann. 

The Toronto-based cannabis company said the products, to be introduced in a phased manner, would include ArthroCBD soft gel capsules, as well as topical cannabinoid applications created to address eczema, psoriasis, and local pain. 

“We continue to innovate and expand our clinically proven cannabinoid product offerings as we launch our initial suite of products formulated with the VESIsorb drug delivery system technology,” said Umar Syed, President of the Medical Division at Heritage. 

READ: Heritage Cannabis expands US supply and distribution agreement with Geocann for products utilizing VESIsorb technology

“With our products, we aim to reach the broader healthcare market that includes sophisticated consumers and healthcare professionals, who are seeking highly effective products that have substantial safety and efficacy data to support their utility for medical applications,” he added.

Heritage Cannabis Holdings Corp (CSE:CANN) (OTCQX:HERTF) revealed  on Tuesday that it has signed an expansion of its US supply and distribution agreement with Geocann LLC for a portfolio of cannabinoid products utilizing the patented VESIsorb delivery system for optimized absorption and stability.

The Toronto-based cannabis company said the agreement includes “strategic channels” in the Canadian marketplace that are currently accessible via the Canadian Cannabis Act, as well as “a platform for growth as regulatory conditions continue to develop.”

Heritage, through its US subsidiary Opticann, signed a supply and distribution agreement in 2020 to exclusively brand and market a select portfolio of VESIsorb formulated oral and topical CBD and CBG products to major US retailers, including CVS Health Corp, Walgreens Boots Alliance Inc, Rite-Aid, Kroger, Costco and Walmart Inc.

READ: Heritage Cannabis says Health Canada has granted it the first-ever license to export cannabis products from Canada to Brazil

“Obtaining the distribution rights for select VESIsorb products in Canada adds to our fast-growing suite of retail and medical product offerings across the country,” said Umar Syed, who is the president of Heritage’s Medical and International business in a statement.

FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) CEO Raza Bokhari talks to Proactive about the group's upcoming shareholder meeting on May 14, intended to address shareholder concerns.

What's more, Bokhari says the company has formed a license agreement with Innovet Italia SRL to develop FDA-approved veterinary drugs for the treatment of gastrointestinal diseases in dogs and cats.

Heritage Cannabis (CSE: CANN- OTCQX: HERTF) CEO Clint Sharples joined Steve Darling from Proactive to share a great deal of news from the company including Health Canada granting Heritage Cannabis a license so the company can now export to Brazil.

Sharples talks more about their strategy for Brazil, and he also shared news the company has hit a major milestone with weekly revenue hitting one million dollars in March.